Investors

Shaping together the future of medical imaging.

Thanks to the continued support of its investors, Intrasense has expanded internationally and has developped a full software suite leveraging image-based management of pathologies. 

We are ambitious. We are passionate. We are achieving. 

Tomorrow. Now. Together.

Financial documentation

Agenda | Publication of half-yearly results : 2017, october 31

If you cannot find the information you are looking for, please do not hesitate to contact our investor relations center. 

Stock exchange information

Identification

Name: Intrasense
Ticker symbol
: ALINS
ISIN code: FR0011179886
Bloomberg: ALINS:FP
Reuters: ALINS.PA
Number of shares: 12,010,449

 NYSE-Alternext-150x150

Capital distribution

 

Analysts coverage

AURGALYS - MICKAEL DUBOURD Download

Investor contact

Intrasense

Stéphane Chemouny, CEO
Christophe Lamboeuf, CFO
37-39, avenue Ledru Rollin | 75012 PARIS (France)
Email: investor@intrasense.fr 

Newcap

Valentine Brouchot and Pierre Laurent
Financial communications and investor relations
Tel: +33 (0)1 44 71 94 96
Email: intrasense@newcap.eu 

Intrasense_blanc

GMED_ISO

map_20161028

Contact
LinkedIn
YouTube
Twitter
Viadeo
WeChat

Headquarters / Siège social :
1231, avenue du Mondial 98
34000 MONTPELLIER | FRANCE